Danielle A. Henry
St. Laurent
QC, Canada
QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The PLK4 inhibitor RP-1664 demonstrates potent single-agent efficacy in neuroblastoma models through a dual mechanism of sensitivity.
Journal: Research square
Published: August 06, 2025
The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivity.
Journal: Nature communications
Published: July 06, 2025
Correction: The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals.
Journal: Clinical proteomics
Published: November 15, 2022
Circulating proteins to predict COVID-19 severity.
Journal: Scientific reports
Published: June 02, 2022
The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals.
Journal: Clinical proteomics
Published: November 15, 2021
A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition.
Journal: Aging cell
Published: December 04, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026